年 〜
年

検索結果 7 件

Trends in patented drug prices (PMPRB study series ; S-9811)

Trends in patented drug prices (PMPRB study series ; S-9811)
紙図書
Ronald J. Corvari.Patented Medicine Prices Review Board1998.<Y629-99-49>
国立国会図書館

International prescription drug parity : are Americans being protected or gouged? : hearing before the Subcommittee on Human Rights and Wellness of the Committee on Government Reform, House of Representatives, One Hundred Eighth Congress, first session, April 3, 2003 Serial no. 108-12 (United States. Congress. House. Committee on Government Reform)

International prescription drug parity : are Americans being protected or gouged? : hearing before the Subcommittee on Human Rights and Wellness of the Committee on Government Reform, House of Representatives, One Hundred Eighth Congress, first session, April 3, 2003 Serial no. 108-12 (United States. Congress. House. Committee on Government Reform)
マイクロ図書
2003<YCA-Y 4.G 74/7:P 92/20>
国立国会図書館
  • 件名... United States Drugs -- Prices -- Canada Drugs -- Prices -- Internatio...

Road map for the next decade : report on the PMPRB's public consultations.

Road map for the next decade : report on the PMPRB's public consultations.
紙図書
Patented Medicine Prices Review Board1998.<Y629-99-48>
国立国会図書館

Prescription drugs [microform] : companies typically charge more in the United States than in Canada : statement of Janet L. Shikles, Director, Health Financing and Policy Issues, Human Resources Division, before the Subcommittee on Health and the Environment, Committee on Energy and Commerce, House of Representatives / United States General Accounting Office (Testimony ; GAO/T-HRD-93-5)

Prescription drugs [microform] : companies typically charge more in the United States than in Canada : statement of Janet L. Shikles, Director, Health Financing and Policy Issues, Human Resources Division, before the Subcommittee on Health and the Environment, Committee on Energy and Commerce, House of Representatives / United States General Accounting Office (Testimony ; GAO/T-HRD-93-5)
マイクロ図書
1993<YCA-GA 1.5/2:T-HRD-93-5>
国立国会図書館
  • 件名Drugs -- Prices -- Canada Drugs -- Prices -- Government...

Prescription drug prices microform : analysis of Canada's Patented Medicine Prices Review Board : report to the Chairman, Special Committee on Aging, U.S. Senate / United States General Accounting Office

Prescription drug prices microform : analysis of Canada's Patented Medicine Prices Review Board : report to the Chairman, Special Committee on Aging, U.S. Senate / United States General Accounting Office
マイクロ図書
1993<YCA-GA 1.13:HRD-93-51>
国立国会図書館
  • 件名...w Board Canada Drugs -- Prices -- Canada Pharmaceutical industry -- Ca...

Compulsory patent licensing of drugs in Canada : have the full price benefits been realized? (Background study)

Compulsory patent licensing of drugs in Canada : have the full price benefits been realized? (Background study)
紙図書
Paul K. Gorecki.Commission of Inquiry on the Pharmaceutical Industry1985.<Y629-87-42>
国立国会図書館

Transfer pricing of drugs and pharmaceutical intermediate products (Background study)

Transfer pricing of drugs and pharmaceutical intermediate products (Background study)
紙図書
G. David Quirin.Commission of Inquiry on the Pharmaceutical Industry1985.<Y629-87-37>
国立国会図書館

検索結果は以上です。